天美传媒

• share
• favorite_border

recent study conducted across nine Iowa hospitals has shown promising results in reducing postoperative opioid prescriptions by implementing Enhanced Recovery After Surgery (ERAS) pathways. The study, led by researchers from the Rothman Opioid Foundation, Goldfinch Health, and Drexel University College of Medicine, examined the impact of ERAS protocols on opioid prescribing to patients undergoing arthroplasty (joint replacement surgery) and arthroscopy (a minimally invasive procedure to diagnose and treat joint issues). Arthroplasty involves replacing damaged joints with prosthetic implants to relieve pain and restore function, whereas arthroscopy utilizes a small camera to examine and repair joint damage through small incisions.

• share
• favorite_border

A new study examining the treatment of xylazine-associated wounds in Philadelphia sheds light on the severe medical complications and healthcare challenges caused by the widespread presence of the drug in the city鈥檚 illicit supply.

• share
• favorite_border

The Appalachian region continues to experience disproportionately higher opioid overdose rates and related fatalities. According to the most recent Center for Disease Control and Prevention, fully one-half of the 16 states with the highest overdose death rates are Appalachian states.

• share
• favorite_border

Opinion piece on using opioid crisis as a blueprint for addressing Xylazine and F2 spread

• share
• favorite_border

Racial Differences in Opioid Use Disorder

• share
• favorite_border

Pennsylvania legislators and top medical experts will come together to address the growing xylazine crisis at an upcoming free symposium. The event, titled "The Next Chapter of the Opioid Epidemic in Pennsylvania: The Xylazine Crisis," will be held on November 23, 2024, at the Bluemle Life Science Building at Jefferson Med in Philadelphia.

• share
• favorite_border

The Rothman Orthopaedic Institute Foundation for Opioid Research & Education announces a symposium titled "The Next Chapter of the Opioid Epidemic in Pennsylvania: The Xylazine Crisis" to be held on November 23, 2024, from 8:30 am to 12:30 pm at the Bluemle Life Science Building at Jefferson Med in Philadelphia.

• share
• favorite_border

A recent study reveals a troubling surge in opioid-related deaths across the Appalachian region, with rural areas suffering the highest rates.

• share
• favorite_border

In 2016, nearly 2 million opioid prescriptions were given to patients across the state. However, by the end of the study period in 2020, there was a 38 percent decrease in opioid prescriptions written, according to this study by Dr. Asif Ilyas.

• share
• favorite_border

In light of the national opioid crisis, a recent study by researchers at the Rothman Orthopaedic Institute and its Department of Medical Cannabis explores the use of medical cannabis (MC) as a potential alternative for chronic pain management.

• share
• favorite_border

Results of a study shows the opioid crisis is not just about the drugs used; it is also about the ones that are not used. The findings, emphasizing the importance of safe drug disposal, are timely as the next National Prescription Drug Take Back Day, sponsored by the US Drug Enforcement Agency (DEA), approaches on April 27, 2024.

• share
• favorite_border

Physician assistants (PAs) and nurse practitioners (NPs) are at the heart of patient care in Appalachia, often taking the lead in managing pain and prescribing medications. Their role is significant, but their training in opioid management falls short when compared to their physician counterparts.

• share
• favorite_border

A Philadelphia-based non-profit foundation is combating the opioid addiction epidemic at the source by educating frontline allied health professionals on various aspects of the nation's opioid crisis, specifically in Pennsylvania and the Appalachian region.